Ernst & Young's 2026 biotech report shows 13% revenue growth to $232B, but US policy shifts, patent cliffs and uneven ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...

A bill before Congress would amend the COINS Act, which restricts American investment in sensitive technologies abroad, to ...

The European Commission is concerned that diverging policies in member states could derail the European Union's Strategy for Life Sciences and Biotechnology. The concern is expressed in the Commission ...

Every biotech lab in the world leaks money in a silent way. Through lost time. Not broken equipment or failed experiments, but from something far less visible: information that exists somewhere in the ...